Rain Therapeutics Probability of Future Stock Price Finishing Over 1.41
| RAINDelisted Stock | USD 1.41 0.01 0.70% |
Rain |
Rain Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Rain Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Rain Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Rain Therapeutics is not yet fully synchronised with the market data | |
| Rain Therapeutics may become a speculative penny stock | |
| Rain Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (72.26 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Rain Therapeutics currently holds about 90.73 M in cash with (65.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.41, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 68.0% of the company shares are owned by institutional investors |
Rain Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Rain Stock often depends not only on the future outlook of the current and potential Rain Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rain Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 28 M | |
| Cash And Short Term Investments | 130.5 M |
Rain Therapeutics Technical Analysis
Rain Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Rain Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Rain Therapeutics. In general, you should focus on analyzing Rain Stock price patterns and their correlations with different microeconomic environments and drivers.
Rain Therapeutics Predictive Forecast Models
Rain Therapeutics' time-series forecasting models is one of many Rain Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Rain Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Rain Therapeutics
Checking the ongoing alerts about Rain Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Rain Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Rain Therapeutics is not yet fully synchronised with the market data | |
| Rain Therapeutics may become a speculative penny stock | |
| Rain Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (72.26 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Rain Therapeutics currently holds about 90.73 M in cash with (65.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.41, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 68.0% of the company shares are owned by institutional investors |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Rain Stock
If you are still planning to invest in Rain Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rain Therapeutics' history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |